Nikko Asset Management Americas’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.9M Sell
6,527
-145
-2% -$64.5K 0.03% 124
2025
Q1
$3.23M Sell
6,672
-707
-10% -$343K 0.04% 115
2024
Q4
$2.97M Sell
7,379
-1,092
-13% -$440K 0.03% 114
2024
Q3
$3.94M Sell
8,471
-3,349
-28% -$1.56M 0.04% 113
2024
Q2
$5.54M Sell
11,820
-3,212
-21% -$1.51M 0.06% 98
2024
Q1
$6.28M Sell
15,032
-2,507
-14% -$1.05M 0.06% 101
2023
Q4
$7.14M Sell
17,539
-1,233
-7% -$502K 0.07% 95
2023
Q3
$6.53M Sell
18,772
-143
-0.8% -$49.7K 0.08% 103
2023
Q2
$6.65M Buy
18,915
+651
+4% +$229K 0.07% 102
2023
Q1
$5.64M Sell
18,264
-1,389
-7% -$429K 0.07% 103
2022
Q4
$5.67M Sell
19,653
-4,951
-20% -$1.43M 0.08% 109
2022
Q3
$7.08M Sell
24,604
-24,981
-50% -$7.19M 0.09% 100
2022
Q2
$13.6M Sell
49,585
-31,950
-39% -$8.79M 0.17% 77
2022
Q1
$21.4M Sell
81,535
-32,454
-28% -$8.51M 0.16% 80
2021
Q4
$24.9M Sell
113,989
-13,207
-10% -$2.88M 0.13% 88
2021
Q3
$23.1M Buy
127,196
+19,115
+18% +$3.47M 0.1% 92
2021
Q2
$21.7M Sell
108,081
-15,166
-12% -$3.04M 0.08% 98
2021
Q1
$26.5M Buy
123,247
+33,798
+38% +$7.26M 0.13% 97
2020
Q4
$21.1M Buy
89,449
+5,457
+6% +$1.29M 0.12% 100
2020
Q3
$22.5M Buy
83,992
+21,429
+34% +$5.75M 0.2% 76
2020
Q2
$17.7M Sell
62,563
-47,860
-43% -$13.6M 0.23% 66
2020
Q1
$26.3M Sell
110,423
-12,467
-10% -$2.97M 0.49% 57
2019
Q4
$26.9M Sell
122,890
-3,264
-3% -$715K 0.42% 62
2019
Q3
$21.4M Buy
126,154
+20,594
+20% +$3.49M 0.38% 61
2019
Q2
$19.4M Buy
105,560
+62,110
+143% +$11.4M 0.38% 60
2019
Q1
$7.99M Buy
+43,450
New +$7.99M 0.21% 78